Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Joint Mobile Emerging Disease Clinical Capability (JMEDICC) laboratory approach: Capabilities for high-consequence pathogen clinical research.
Naluyima P, Kayondo W, Ritchie C, Wandege J, Kagabane S, Tumubeere L, Kusiima B, Kibombo D, Atukunda S, Nanteza C, Nabirye H, Mugabi FB, Namuyanja S, Hatcher C, Rauch H, Mukembo M, Musinguzi P; JMEDICC Consortium; Sanders N, Turesson E, Cando C, Walwema R, Mimbe D, Hepburn J, Clark D, Lamorde M, Kibuuka H, Zaman S, Cardile AP, Martins KA. Naluyima P, et al. PLoS Negl Trop Dis. 2019 Dec 19;13(12):e0007787. doi: 10.1371/journal.pntd.0007787. eCollection 2019 Dec. PLoS Negl Trop Dis. 2019. PMID: 31856153 Free PMC article. Review.
Pre-positioned Outbreak Research: The Joint Medical Emerging Diseases Intervention Clinical Capability Experience in Uganda.
Martins KA, Ayebare RR, Bhadelia N, Kiweewa F, Waitt P, Mimbe D, Okello S, Naluyima P, Brett-Major DM, Lawler JV, Millard M, Walwema R, Cardile AP, Ritchie C, Kwiecien A, Badu H, Espinosa BJ, Beckett C, Bavari S, Zaman S, Christopher G, Clark DV, Lamorde M, Kibuuka H. Martins KA, et al. Among authors: naluyima p. Health Secur. 2020 Mar/Apr;18(2):114-124. doi: 10.1089/hs.2019.0112. Health Secur. 2020. PMID: 32324070
Safety, tolerability, and immunogenicity of the Ebola Sudan chimpanzee adenovirus vector vaccine (cAd3-EBO S) in healthy Ugandan adults: a phase 1, open-label, dose-escalation clinical trial.
Mwesigwa B, Houser KV, Hofstetter AR, Ortega-Villa AM, Naluyima P, Kiweewa F, Nakabuye I, Yamshchikov GV, Andrews C, O'Callahan M, Strom L, Schech S, Anne Eller L, Sondergaard EL, Scott PT, Amare MF, Modjarrad K, Wamala A, Tindikahwa A, Musingye E, Nanyondo J, Gaudinski MR, Gordon IJ, Holman LA, Saunders JG, Costner PJM, Mendoza FH, Happe M, Morgan P, Plummer SH, Hickman SP, Vazquez S, Murray T, Cordon J, Dulan CNM, Hunegnaw R, Basappa M, Padilla M, Gajjala SR, Swanson PA 2nd, Lin BC, Coates EE, Gall JG, McDermott AB, Koup RA, Mascola JR, Ploquin A, Sullivan NJ, Kibuuka H, Ake JA, Ledgerwood JE; RV 508 Study Team. Mwesigwa B, et al. Among authors: naluyima p. Lancet Infect Dis. 2023 Dec;23(12):1408-1417. doi: 10.1016/S1473-3099(23)00344-4. Epub 2023 Aug 3. Lancet Infect Dis. 2023. PMID: 37544326 Clinical Trial.
In-vitro Immunomodulatory activity of Azadirachta indica A.Juss. Ethanol: water mixture against HIV associated chronic CD4+ T-cell activation/ exhaustion.
Olwenyi OA, Asingura B, Naluyima P, Anywar GU, Nalunga J, Nakabuye M, Semwogerere M, Bagaya B, Cham F, Tindikahwa A, Kiweewa F, Lichter EZ, Podany AT, Fletcher CV, Byrareddy SN, Kibuuka H. Olwenyi OA, et al. Among authors: naluyima p. BMC Complement Med Ther. 2021 Apr 9;21(1):114. doi: 10.1186/s12906-021-03288-0. BMC Complement Med Ther. 2021. PMID: 33836748 Free PMC article.
Transient Reductions in Human Immunodeficiency Virus (HIV) Clinic Attendance and Food Security During the Coronavirus Disease 2019 (COVID-19) Pandemic for People Living With HIV in 4 African Countries.
Dear N, Duff E, Esber A, Parikh A, Iroezindu M, Bahemana E, Kibuuka H, Owuoth J, Maswai J, Crowell TA, Ake JA, Polyak CS; AFRICOS Study Group. Dear N, et al. Clin Infect Dis. 2021 Nov 16;73(10):1901-1905. doi: 10.1093/cid/ciab379. Clin Infect Dis. 2021. PMID: 33906235 Free PMC article.
24 results